Aspirin-Like Drug Lowers Blood Sugar in Diabetics

An aspirin-like drug appears to lower blood sugar in people with type 2 diabetes, according to new research.

A study of the drug -- the prescription pain reliever salsalate -- also found it reduced inflammation associated with type 2 diabetes. But it produced unwelcome side effects that could limit its potential as a diabetes treatment.

"This trial is a test of possibly the oldest drug in Western use, and, because it's so old, there are no clinical trials on it," said study senior author Dr. Steven Shoelson, a professor of medicine at Harvard Medical School in Boston.

"This trial was for a full year and showed that salsalate does lower blood glucose," said Shoelson, who is also the associate research director at the Joslin Diabetes Center in Boston.

The study, published in the July 2 issue of the Annals of Internal Medicine, included 286 people between 18 and 75 years old with type 2 diabetes. Type 2 diabetes occurs when the body no longer produces enough of the hormone insulin to convert carbohydrates from food into fuel for the body.

Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Health-News/aspirin-Type-2-diabetes-salsalate-inflammation/2013/07/02/id/513012#ixzz2XuzbzhNO
Alert: What Is Your Risk for a Heart Attack? Find Out Now
Enhanced by Zemanta

No comments: